LYFAX Mutual Fund

NAV$18.22
Showing 10 of 63 holdings(as of Mar 31, 2026)Top 10 Weight: 46.76%
#TickerNameWeightSharesMkt ValueShare ChgSectorIndustry
1FXFXXFirst Am Treas Obli-X7.72%-$3.04M••••••••••••••••••••••
2GILDGilead Sciences Inc7.18%20,260$2.82M••••••••••••••••••••••
3AZN:LNAstrazeneca Plc5.63%11,232$2.22M••••••••••••••••••••••
4VRTXNvaesrtex Pharmaceuticals Inc5.60%4,931$2.20M••••••••••••••••••••••
5IONSIonis Pharmaceuticals Inc3.74%19,587$1.47M••••••••••••••••••••••
6INSMInsmed Inc Sedol 26144873.57%8,583$1.40M••••••••••••••••••••••
7INCYIncyte Corp.3.41%14,245$1.34M••••••••••••••••••••••
8ROIVRoivant Sciences Ltd3.36%47,667$1.32M••••••••••••••••••••••
9ARGX:ASArgenx Se Spon Adr Each Rep 1 Ord Shs3.33%1,794$1.31M••••••••••••••••••••••
10NBIXNeurocrine Bioscienc3.22%9,607$1.27M••••••••••••••••••••••
Want to see all 63 holdings?View All HoldingsPRO

Top Holdings Themes

Interest RatesPharmaceuticalsImmunologyOncologyBiotechnologyLife Sciences ToolsBiotechnology Tools

LYFAX Mutual Fund Top Holdings

LYFAX holdings top 10 positions. The top 10 holdings account for 46.8% of the fund, led by First Am Treas Obli-X at 7.7%, Gilead Sciences Inc at 7.2%, Astrazeneca Plc at 5.6%.

LYFAX portfolio concentration is moderate, with the top 10 representing 46.8% of total assets. The largest sector exposure is Health Care at 79.0%.

LYFAX sector allocation provides a detailed breakdown. LYFAX overlap tool shows how holdings compare to other funds in your portfolio.